T cell responses are governed by avidity and co-stimulatory thresholds

被引:101
|
作者
Bachmann, MF
Sebzda, E
Kundig, TM
Shahinian, A
Speiser, DE
Mak, TW
Ohashi, PS
机构
[1] ONTARIO CANC INST,DEPT IMMUNOL,TORONTO,ON M5G 2M9,CANADA
[2] AMGEN INST,TORONTO,ON,CANADA
关键词
CD28; avidity; activation; T cell; virus;
D O I
10.1002/eji.1830260908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed the avidity and CD28-mediated co-stimulatory requirements for the activation of T cells in vivo and in vitro. The strength of the T cell/antigen-presenting cell interaction was varied by using altered peptide ligands for stimulation. Co-stimulatory requirements were studied using T cells from CD28-deficient mice. The results indicate that T cell activation is not an all-or-nothing event, but occurs in distinct steps. For each step, a certain avidity, co-stimulatory threshold or both, must be met. Depending upon the strength of the interaction between the T cell receptor and the major histocompatibility complex/peptide and the presence of CD28 co-stimulatory signals, T cells may undergo blast formation alone or proliferate or eventually both proliferate and differentiate to effector cells. Thus, T cell activation is governed by both avidity and co-stimulatory thresholds.
引用
收藏
页码:2017 / 2022
页数:6
相关论文
共 50 条
  • [41] Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
    Sugamura, K
    Ishii, N
    Weinberg, AD
    NATURE REVIEWS IMMUNOLOGY, 2004, 4 (06) : 420 - 431
  • [42] Influence of CAR co-stimulatory domains on downstream signaling and CAR-T cell exhaustion
    Kouro, Taku
    Mano, Yasunobu
    Kasajima, Rika
    Hoshino, Daisuke
    Tsuji, Shoutaro
    Imai, Kohzoh
    Sasada, Tetsuro
    CANCER SCIENCE, 2025, 116 : 513 - 513
  • [43] CD28 expression and co-stimulatory capacity in porcine T-cell subsets
    Uehlein, S.
    Gerner, W.
    Schmidt, S.
    Wolf, N.
    Ding, X.
    Herrmann, T.
    Hofmann, U.
    Frey, A.
    Saalmueller, A.
    Kerkau, T.
    Beyersdorf, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 51 - 51
  • [44] A CLDN 18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy
    Liang, Jie
    Zhang, Huihui
    Huang, Yue
    Fan, Lilv
    Li, Fanlin
    Li, Min
    Yan, Yaping
    Zhang, Junshi
    Li, Zeyu
    Yang, Xuanming
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6977 - 6987
  • [45] T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
    Beier, K. C.
    Kallinich, T.
    Hamelmann, E.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (02) : 383 - 390
  • [46] Prostaglandin B2 delivers a co-stimulatory signal leading to T cell activation
    Cattan, N
    Mary, D
    Peleraux, A
    Mari, B
    Aussel, C
    Rossi, B
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (02) : 293 - 299
  • [48] Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
    Kazuo Sugamura
    Naoto Ishii
    Andrew D. Weinberg
    Nature Reviews Immunology, 2004, 4 : 420 - 431
  • [49] Influence of Ertapenem on Cell Activation and Co-Stimulatory Molecule Expressions
    Korzh, Oleksiy
    Krasnokutskiy, Sergey
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S110 - S110
  • [50] CD27 is a new promising T cell co-stimulatory target for cancer immunotherapy
    Guillaudeux, Thierry
    Ovechkina, Yulia
    Lustig, Kurt
    Iadonato, Shawn
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (12)